Research Solutions (RSSS) Competitors

Research Solutions (NASDAQ:RSSS) and OptimizeRx (NASDAQ:OPRX) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability.

Is RSSS or OPRX more profitable?

Research Solutions has a net margin of -8.03% compared to OptimizeRx's net margin of -9.42%. OptimizeRx's return on equity of 4.50% beat Research Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Research Solutions	-8.03%	-5.80%	-1.59%
OptimizeRx	-9.42%	4.50%	3.12%

Which has higher valuation and earnings, RSSS or OPRX?

Research Solutions has higher earnings, but lower revenue than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than Research Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Research Solutions	$44.62M	2.14	-$3.79M	-$0.14	-21.00
OptimizeRx	$104.75M	3.06	-$18.66M	-$0.54	-31.94

Which has more volatility and risk, RSSS or OPRX?

Research Solutions has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500.

Do analysts recommend RSSS or OPRX?

OptimizeRx has a consensus target price of $11.81, suggesting a potential downside of 31.52%. Given OptimizeRx's stronger consensus rating and higher probable upside, analysts plainly believe OptimizeRx is more favorable than Research Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Research Solutions	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
OptimizeRx	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Do institutionals & insiders have more ownership in RSSS or OPRX?

33.6% of Research Solutions shares are owned by institutional investors. Comparatively, 76.5% of OptimizeRx shares are owned by institutional investors. 12.9% of Research Solutions shares are owned by company insiders. Comparatively, 5.6% of OptimizeRx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Does the media favor RSSS or OPRX?

In the previous week, Research Solutions had 4 more articles in the media than OptimizeRx. MarketBeat recorded 10 mentions for Research Solutions and 6 mentions for OptimizeRx. OptimizeRx's average media sentiment score of 0.74 beat Research Solutions' score of 0.65 indicating that OptimizeRx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Research Solutions	1 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OptimizeRx	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

OptimizeRx beats Research Solutions on 10 of the 16 factors compared between the two stocks.